Boston Scientific Corp
(FRA:BSX)
€
38.95
+0.17 (+0.43%)
Market Cap: 58.43 Bil
Enterprise Value: 67.05 Bil
PE Ratio: 18.73
PB Ratio: 2.57
GF Score: 74/100 
Boston Scientific Corp at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019 / 03:00PM GMT
Release Date Price:
€33.03
(+0.32%)
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research
Good to go here. Thanks, everybody, for coming out early. Las Vegas time anyway. I'm Bob Hopkins from BofA, and I want to say thank you very much to the Boston Scientific team for being here this morning. This is a fireside chat format. We have Dan Brennan, obviously, the company's Chief Financial Officer; and Susie Lisa, who runs Investor Relations. And just thrilled to have you guys here. Thank you.
Susan Vissers Lisa
Boston Scientific Corporation - VP of IR
Thanks, Bob.
Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO
Pleasure to be here. Thanks for the invite.
Robert Adam Hopkins;Daniel J. Brennan
BofA Merrill Lynch, Research Division - MD of Equity Research;Boston Scientific
Dan, I don't know if there's a quick opening kind of message you want to deliver, or we'll just hop right into Q&A. Either way is fine with me.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers